Cargando…

The therapeutic efficacy of denosumab for the loss of bone mineral density in glucocorticoid-induced osteoporosis: a meta-analysis

OBJECTIVE: Prevention of steroidal osteoporosis is an important issue. There is no clear consensus on the impact of anti-RANKL antibody (denosumab) on BMD in patients with glucocorticoid-induced osteoporosis (GIO). In this study, we aimed to evaluate the impact of denosumab on BMD loss in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamaguchi, Yuta, Morita, Takayoshi, Kumanogoh, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197806/ https://www.ncbi.nlm.nih.gov/pubmed/32373775 http://dx.doi.org/10.1093/rap/rkaa008

Ejemplares similares

Therapeutic efficacy of denosumab for rheumatoid arthritis: a systematic review and meta-analysis
por: Yagita, Mayu, et al.
Publicado: (2021)

Correlations Between Abnormal Glucose Metabolism and Bone Mineral Density or Bone Metabolism
por: Qu, Yang, et al.
Publicado: (2016)

Single and Combined use of Human Parathyroid Hormone (PTH) (1-34) on Areal Bone Mineral Density (aBMD) in Postmenopausal Women with Osteoporosis: Evidence Based on 9 RCTs
por: Song, Jiefu, et al.
Publicado: (2014)

Denosumab improves bone mineral density and microarchitecture and reduces bone pain in women with osteoporosis with and without glucocorticoid treatment
por: Petranova, Tzvetanka, et al.
Publicado: (2014)

Effects of Denosumab on Bone Metabolic Markers and Bone Mineral Density in Patients Treated with Glucocorticoids
por: Sawamura, Masato, et al.
Publicado: (2017)

Association between essential hypertension and bone mineral density: a systematic review and meta-analysis
por: Ye, Ziliang, et al.
Publicado: (2017)

Associations between bone mineral density and coronary artery calcification: a systematic review and meta-analysis
por: Zhang, Peiyu, et al.
Publicado: (2022)

Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
por: Chen, Yi, et al.
Publicado: (2021)

Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials
por: Mastrantoni, Luca, et al.
Publicado: (2023)

Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis
por: Sánchez, A., et al.
Publicado: (2016)

Influence of denosumab on bone mineral density in a severe case of pregnancy-associated osteoporosis
por: Stumpf, U., et al.
Publicado: (2021)

Relationship Between Glucocorticoids and Insulin Resistance in Healthy Individuals
por: Zhou, Peng-Zhen, et al.
Publicado: (2016)

Assessment of Distal Radius Bone Mineral Density in Osteoporosis Patients Receiving Denosumab, Including Those with Rheumatoid Arthritis and Those Receiving Oral Glucocorticoids
por: Matsuno, Hiroaki
Publicado: (2016)

Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis
por: Hu, Mingwei, et al.
Publicado: (2023)

Efficacy of glucocorticoids, vitamin A and caffeine therapies for neonatal mortality in preterm infants: a network meta-analysis
por: Li, Ying, et al.
Publicado: (2017)

Microscopic colitis is a risk factor for low bone density: a systematic review and meta-analysis
por: Rancz, Anett, et al.
Publicado: (2023)

Pharmacological Therapies for Osteoporosis: A Bayesian Network Meta-Analysis
por: Shen, Jiping, et al.
Publicado: (2022)

Efficacy and safety of bisphosphonates on childhood osteoporosis secondary to chronic illness or its treatment: a meta-analysis
por: Zhao, Huawei, et al.
Publicado: (2022)

Glucocorticoid Regimens in the Treatment of Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
por: Whittle, Emma, et al.
Publicado: (2019)

Efficacy and Safety of Different Bisphosphonates for Bone Loss Prevention in Kidney Transplant Recipients: A Network Meta-Analysis of Randomized Controlled Trials
por: Yang, Yan, et al.
Publicado: (2018)

Efficacy of topical vs intravenous tranexamic acid in reducing blood loss and promoting wound healing in bone surgery: A systematic review and meta-analysis
por: Xu, Jian-Wen, et al.
Publicado: (2021)

ABCB1 Gene Polymorphisms and Glucocorticoid-Induced Avascular Necrosis of the Femoral Head Susceptibility: A Meta-Analysis
por: Li, Zhigang, et al.
Publicado: (2014)

Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis
por: Suzuki, Takako, et al.
Publicado: (2018)

Comparison of Denosumab and Zoledronic Acid in Postmenopausal Women With Osteoporosis: Bone Mineral Density (BMD) and Trabecular Bone Score (TBS)
por: Kang, Taewook, et al.
Publicado: (2022)

Effects of glucocorticoid use on survival of advanced non-small-cell lung cancer patients treated with immune checkpoint inhibitors
por: Li, Nijiao, et al.
Publicado: (2023)

Bone Mineral Density After Transitioning From Denosumab to Alendronate
por: Kendler, David, et al.
Publicado: (2019)

Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis
por: Dempster, David W, et al.
Publicado: (2018)

The comparable efficacy of denosumab on bone mineral density in rheumatoid arthritis patients with postmenopausal osteoporosis: A retrospective case-control study
por: Kim, Seong-Kyu, et al.
Publicado: (2023)

Forkhead box F2 as a novel prognostic biomarker and potential therapeutic target in human cancers prone to bone metastasis: a meta-analysis
por: Chen, Qing, et al.
Publicado: (2021)

The reduction of concomitant glucocorticoids dosage following treatment with IL-1 receptor antagonist in adult onset Still’s disease. A systematic review and meta-analysis of observational studies
por: Ruscitti, Piero, et al.
Publicado: (2020)

Comparative efficacy and safety of bone-modifying agents for the treatment of bone metastases in patients with advanced renal cell carcinoma: a systematic review and meta-analysis
por: Omae, Kenji, et al.
Publicado: (2017)

Microvessel density in differentiated thyroid carcinoma: A systematic review and meta-analysis
por: Perivoliotis, Konstantinos, et al.
Publicado: (2022)

A meta-analysis of the lymphatic microvessel density and survival in gastric cancer with 1809 cases
por: Liang, Liang, et al.
Publicado: (2017)

Microvessel density in patients with gastrointestinal stromal tumors: A systematic review and meta-analysis
por: Perivoliotis, Konstantinos, et al.
Publicado: (2023)

Prognostic value of endoglin-assessed microvessel density in cancer patients: a systematic review and meta-analysis
por: Zhang, Jinguo, et al.
Publicado: (2017)

Baseline Characteristics and Changes in Bone Mineral Density T-Scores of Bulgarian Women with Postmenopausal Osteoporosis Receiving Denosumab in Routine Clinical Practice
por: Boyanov, Mihail, et al.
Publicado: (2016)

Comparing alveolar bone regeneration using Bio-Oss and autogenous bone grafts in humans: a systematic review and meta-analysis
por: Akbarzadeh Baghban, Alireza, et al.
Publicado: (2009)

Can polysaccharide K improve therapeutic efficacy and safety in gastrointestinal cancer? a systematic review and network meta-analysis
por: Ma, Yan, et al.
Publicado: (2017)

Comparison of (18)FDG PET/PET-CT and bone scintigraphy for detecting bone metastases in patients with nasopharyngeal cancer: a meta-analysis
por: Xu, Chuanhui, et al.
Publicado: (2017)

Effect of lateral bone augmentation procedures in correcting peri‐implant bone dehiscence and fenestration defects: A systematic review and network meta‐analysis
por: Severi, Mattia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vdldr9en6cvtc6rkvs1guroa12